Core Viewpoint - GigaCloud Technology Inc. (GCT) shows a promising earnings outlook with analysts raising their earnings estimates, indicating potential for continued stock momentum [1][2]. Earnings Estimate Revisions - The trend in estimate revisions reflects growing analyst optimism, which is expected to positively impact the stock price [2]. - The current-quarter earnings estimate is $0.65 per share, a decrease of 14.5% from the previous year, but has increased by 20.37% over the last 30 days due to one upward revision [5]. - For the full year, the earnings estimate is $3.20 per share, representing a 4.9% increase from the previous year, with a consensus estimate increase of 7.74% following one upward revision [6][7]. Zacks Rank - GigaCloud Technology Inc. holds a Zacks Rank 1 (Strong Buy), indicating strong potential for outperformance based on favorable estimate revisions [8]. - Historically, Zacks Rank 1 stocks have generated an average annual return of +25% since 2008, suggesting a strong investment opportunity [3]. Stock Performance - The stock has gained 13.8% over the past four weeks, driven by solid estimate revisions, making it a candidate for portfolio addition [9].

National Health Investors (NHI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.I ...

American Express (AXP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power ...

CenterPoint Energy (CNP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors oft ...

Investors might want to bet on Bilibili (BILI) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings ...

Ekso Bionics (EKSO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investor ...

Merit Medical (MMSI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors oft ...

Western Digital (WDC) closed the last trading session at $140.23, gaining 11.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $175.64 indicates a 25.3% upside potential.The mean estimate comprises 22 short-term price targets with a standard deviation of $29.75. While the lowest estimate of $95.00 indicates a 32.3% decline from the current price level, the most optimistic analyst ...

Palomar (PLMR) closed the last trading session at $121.66, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $155.67 indicates a 28% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $14.62. While the lowest estimate of $134.00 indicates a 10.1% increase from the current price level, the most optimistic analyst expects t ...

Calix (CALX) has been beaten down lately with too much selling pressure. While the stock has lost 11.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price mov ...